Small non-coding RNAs as regulators of structural evolution and carcinogenesis

Non-coding RNA Research
Oxana V Klimenko

Abstract

Small non-coding RNAs (sncRNAs) are part of non-coding oligonucleotide regulators with wide physiologic and morphologic functions. They control genetic programing of cells, and may modulate processes of differentiation and death. Biogenesis of sncRNAs is now known, and some sncRNAs have been proposed as markers of malignization. Epigenetic therapy is based on the use of newly discovered genetic modifiers, such as sncRNAs, micro-RNAs, and theirs mimics. However, role of sncRNAs in structural evolution and mechanisms of adaptation is not clearly understood. Certainly, non-coding RNAs participate in processes of cellular and organismal adaptation as well as cellular and tissue structural transformation as response to changing of environmental neighbouring. Investigations into these functions of sncRNAs may be the basis of future epigenetic environmental medicine.

Citations

Aug 10, 2019·Archives of Physiology and Biochemistry·Marwa MatboliMarwa Ali
Aug 25, 2018·Integrative Biology : Quantitative Biosciences From Nano to Macro·Y OnishiN Kubota
Mar 8, 2019·Wiley Interdisciplinary Reviews. RNA·Vincent BoivinSherif Abou-Elela
Aug 23, 2020·Gene·Zhuang JingHan Shuwen
Jan 10, 2021·Seminars in Cancer Biology·Imran AnsariSaurabh Singh
Jan 2, 2021·Critical Reviews in Oncology/hematology·Shokooh SalimimoghadamBehzad Baradaran
Aug 28, 2021·Biomedicines·Sedigheh FalahiYvonne Joseph
Dec 5, 2020·Seminars in Cancer Biology·Shahnawaz RehmanMohd Farhan

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
light microscopy

Software Mentioned

GLOBOCAN

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Evolution; International Journal of Organic Evolution
Douglas R Cavener
Progress in Experimental Tumor Research
F Homburger, A Tregier
Journal of the Association of Genetic Technologists
Tarek Bachour, Katie Bennett
© 2022 Meta ULC. All rights reserved